Comparison of Outcomes With Multifocal Intraocular Lenses

Recruiting N/A Interventional Study
Cataract
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Wenzhou Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to compare and evaluate the clinical outcomes of 6 kinds of Multifocal Intraocular Lenses: SN6AD1, SBL-3, LS-313 MF30, AT LISA tri 839 MP, ART, LS-313 MF30T.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age from 40 to 80 years old, either gender; * Patients with bilateral age related cataracts, require bilateral cataract phacoemulsification combined Intraocular Lens implantation; * Willing to undergo second eye surgery within 7 days after first eye surgery; * The potential po…
Contacts

AYong Yu, MD. PhD.

+86-0577-88068880

yaybetter@hotmail.com

CONTACT